Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8485373 | Vaccine | 2018 | 8 Pages |
Abstract
We found that vaccinating pregnant women with aP-containing vaccine to prevent neonatal and unvaccinated infants from pertussis-associated disease in Japan can be cost-effective from societal perspective, under the WHO-suggested “cost-effective” criteria (1 to 3 times of GDP). Pertussis is expected be designated as a notifiable disease in 2018, re-analysis should be conducted when straightforward incidence data is available.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Shu-ling Hoshi, Xerxes Seposo, Ichiro Okubo, Masahide Kondo,